JP2012162557A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012162557A5 JP2012162557A5 JP2012090664A JP2012090664A JP2012162557A5 JP 2012162557 A5 JP2012162557 A5 JP 2012162557A5 JP 2012090664 A JP2012090664 A JP 2012090664A JP 2012090664 A JP2012090664 A JP 2012090664A JP 2012162557 A5 JP2012162557 A5 JP 2012162557A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- weight
- composition according
- skin penetration
- physiologically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 210000003491 skin Anatomy 0.000 claims 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- 239000013543 active substance Substances 0.000 claims 6
- 239000002904 solvent Substances 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 5
- 239000003961 penetration enhancing agent Substances 0.000 claims 5
- 239000000126 substance Substances 0.000 claims 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 4
- 230000035515 penetration Effects 0.000 claims 4
- 238000007789 sealing Methods 0.000 claims 4
- 238000001704 evaporation Methods 0.000 claims 3
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 claims 3
- 229960002428 fentanyl Drugs 0.000 claims 3
- 229960003921 octisalate Drugs 0.000 claims 3
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 claims 3
- 239000002244 precipitate Substances 0.000 claims 3
- 230000001737 promoting effect Effects 0.000 claims 3
- WYWZRNAHINYAEF-AWEZNQCLSA-N [(2s)-2-ethylhexyl] 4-(dimethylamino)benzoate Chemical compound CCCC[C@H](CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-AWEZNQCLSA-N 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 2
- 230000000975 bioactive effect Effects 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000003623 enhancer Substances 0.000 claims 2
- 229960002638 padimate o Drugs 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- 238000010521 absorption reaction Methods 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000000339 bright-field microscopy Methods 0.000 claims 1
- 238000000113 differential scanning calorimetry Methods 0.000 claims 1
- 210000002615 epidermis Anatomy 0.000 claims 1
- 230000008020 evaporation Effects 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 210000000434 stratum corneum Anatomy 0.000 claims 1
- 230000037317 transdermal delivery Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39108102P | 2002-06-25 | 2002-06-25 | |
| US60/391,081 | 2002-06-25 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004514440A Division JP5160018B2 (ja) | 2002-06-25 | 2003-06-24 | 非晶質医薬組成物を用いる経皮送達速度調節 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012162557A JP2012162557A (ja) | 2012-08-30 |
| JP2012162557A5 true JP2012162557A5 (enExample) | 2012-12-06 |
| JP5568108B2 JP5568108B2 (ja) | 2014-08-06 |
Family
ID=30000668
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004514440A Expired - Fee Related JP5160018B2 (ja) | 2002-06-25 | 2003-06-24 | 非晶質医薬組成物を用いる経皮送達速度調節 |
| JP2012090664A Expired - Fee Related JP5568108B2 (ja) | 2002-06-25 | 2012-04-12 | 非晶質医薬組成物を用いる経皮送達速度調節 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004514440A Expired - Fee Related JP5160018B2 (ja) | 2002-06-25 | 2003-06-24 | 非晶質医薬組成物を用いる経皮送達速度調節 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US8357393B2 (enExample) |
| EP (2) | EP1534235B1 (enExample) |
| JP (2) | JP5160018B2 (enExample) |
| KR (2) | KR20100055542A (enExample) |
| AU (1) | AU2003240301B2 (enExample) |
| BR (1) | BRPI0312007B1 (enExample) |
| CA (1) | CA2489865C (enExample) |
| EA (1) | EA009024B1 (enExample) |
| ES (1) | ES2589077T3 (enExample) |
| NZ (1) | NZ537360A (enExample) |
| WO (1) | WO2004000263A1 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
| DE19814084B4 (de) * | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung |
| DE10041478A1 (de) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
| US20050181032A1 (en) * | 2002-06-25 | 2005-08-18 | Acrux Dds Pty Ltd. | Metastable pharmaceutical compositions |
| EP1534235B1 (en) * | 2002-06-25 | 2016-07-27 | Acrux DDS Pty Ltd | Transdermal delivery rate control using amorphous pharmaceutical compositions |
| US20050186141A1 (en) * | 2002-06-25 | 2005-08-25 | Acrux Dds Pty Ltd. | Transdermal aerosol compositions |
| US8246980B2 (en) * | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system |
| US8211462B2 (en) * | 2002-07-30 | 2012-07-03 | Ucb Pharma Gmbh | Hot-melt TTS for administering rotigotine |
| DE10234673B4 (de) * | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren |
| US8246979B2 (en) | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system for the administration of rotigotine |
| ES2239196T3 (es) * | 2002-12-02 | 2005-09-16 | Schwarz Pharma Ag | Suministro iontoforetico de rotigotina para el tratamiento de la enfermedad de parkinson. |
| DE10261696A1 (de) * | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base |
| GB0306859D0 (en) * | 2003-03-25 | 2003-04-30 | Arachnova Therapeutics Ltd | Topical formulation and use of buspirone |
| GB0319874D0 (en) * | 2003-08-22 | 2003-09-24 | Glaxo Group Ltd | Novel formulation |
| US20060263421A1 (en) | 2005-05-18 | 2006-11-23 | Abeille Pharmaceuticals Inc | Transdermal Method and Patch for Nausea |
| WO2006128255A1 (en) * | 2005-06-03 | 2006-12-07 | Acrux Dds Pty Ltd | Method and composition for transdermal drug delivery |
| ES2607454T3 (es) | 2005-06-03 | 2017-03-31 | Acrux Dds Pty Ltd | Método y composición para el suministro transdérmico de testosterona |
| US20070065494A1 (en) * | 2005-08-03 | 2007-03-22 | Watson Laboratories, Inc. | Formulations and Methods for Enhancing the Transdermal Penetration of a Drug |
| CN101600730B (zh) | 2006-10-12 | 2014-01-29 | Bhi有限合资公司 | 递送3-氨基-1-丙磺酸的方法、化合物、组合物和载体 |
| JP5114496B2 (ja) | 2007-01-11 | 2013-01-09 | アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド | 拡散器具 |
| AR068409A1 (es) * | 2007-09-14 | 2009-11-18 | Drugtech Corp | Composiciones farmaceuticas, transdermicas sin alcohol |
| AR068408A1 (es) * | 2007-09-14 | 2009-11-18 | Drugtech Corp | Pulverizacion de hormonas transdermicas |
| JP2011502172A (ja) * | 2007-11-02 | 2011-01-20 | アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド | ホルモンおよびステロイド用の経皮送達システム |
| KR100929560B1 (ko) * | 2008-01-09 | 2009-12-03 | 에코 퍼시픽 엘티디 | 그라니세트론을 함유한 매트릭스 형태의 경피 흡수제 |
| US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
| KR101292768B1 (ko) * | 2010-04-23 | 2013-08-05 | 아이큐어 주식회사 | 경피 흡수 제제 |
| CN108186611A (zh) | 2010-04-30 | 2018-06-22 | 帝国制药美国公司 | 丙炔基氨基茚满透皮组合物 |
| SG10201803321TA (en) * | 2010-12-02 | 2018-06-28 | Ferring Int Center Sa | Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate |
| CA2827435C (en) * | 2011-02-15 | 2018-11-27 | Eli Lilly And Company | Methods for controlling pain in canines using a transdermal solution of fentanyl |
| EP2675454B1 (en) * | 2011-02-15 | 2020-01-22 | Audevard | Methods for controlling pain in equines using a transdermal solution of fentanyl |
| KR101853082B1 (ko) | 2011-03-24 | 2018-04-27 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 활성제층 및 활성제 변환층을 포함하는 경피 조성물 |
| EP2776020B1 (en) | 2011-11-09 | 2019-09-11 | Teikoku Seiyaku Co., Ltd. | Methods for the treatment of skin neoplasms |
| AU2013338243B2 (en) | 2012-11-02 | 2016-09-29 | Teikoku Seiyaku Co., Ltd. | Propynylaminoindan transdermal compositions |
| EP2968248A4 (en) * | 2013-03-15 | 2016-08-31 | Nal Pharmaceutical Group Ltd | TRANSDERMAL ACTIVE COMPOSITION SYSTEM WITH RIVASTIGMIN |
| USD750788S1 (en) | 2013-11-26 | 2016-03-01 | Acrux Dds Pty Ltd | Topical spreading applicator |
| USD749225S1 (en) | 2013-11-26 | 2016-02-09 | Acrux Dds Pty Ltd | Topical spreading applicator |
| US8785426B1 (en) | 2013-12-13 | 2014-07-22 | Upsher-Smith Laboratories, Inc. | Testosterone gel compositions and related methods |
| BR112017020358A2 (pt) | 2015-03-23 | 2018-07-17 | Biopharmx Inc | composição farmacêutica de tetraciclina para uso dermatológico |
| JP2018177724A (ja) * | 2017-04-18 | 2018-11-15 | 花王株式会社 | 外用薬 |
| WO2019140087A1 (en) * | 2018-01-10 | 2019-07-18 | Celista Pharmaceuticals Llc | Testosterone transdermal spray with film |
| US12186326B2 (en) * | 2018-07-05 | 2025-01-07 | Celista Pharmaceuticals Llc | Testosterone and estradiol transdermal spray |
Family Cites Families (97)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE555319A (enExample) | 1956-03-21 | 1900-01-01 | ||
| GB1192003A (en) | 1966-05-25 | 1970-05-13 | Struthers Scientific Int Corp | Improvements in or relating to Hair Dressing Preparation |
| GB1258394A (enExample) | 1968-01-17 | 1971-12-30 | ||
| GB1560401A (en) | 1976-01-28 | 1980-02-06 | Unilever Ltd | Skin treatment composition |
| DE2920500A1 (de) | 1979-05-21 | 1980-11-27 | Boehringer Sohn Ingelheim | Pharmazeutische zubereitung in form eines polyacrylatfilmes |
| US4506803A (en) * | 1982-08-09 | 1985-03-26 | Hoffmann-La Roche Inc. | Metered aerosol dispenser and method of using the dispenser |
| DE3311700A1 (de) * | 1983-03-30 | 1984-10-04 | Bayer Ag | Antimykotische mittel mit hoher wirkstoff-freisetzung in form von loesung und spray |
| US4912124A (en) * | 1984-02-23 | 1990-03-27 | Ortho Pharmaceutical Corporation | Antifungal dermatological solution |
| US4824676A (en) | 1984-10-11 | 1989-04-25 | Schering Corporation | Physiological means of enhancing transdermal delivery of drugs |
| US5008111A (en) | 1984-10-11 | 1991-04-16 | Schering Corporation | Physiological means of enhancing transdermal delivery of drugs |
| US4820724A (en) | 1986-03-31 | 1989-04-11 | University Of Southern California | Dual phase solvent carrier system |
| US5114946A (en) | 1987-06-12 | 1992-05-19 | American Cyanamid Company | Transdermal delivery of pharmaceuticals |
| US5474783A (en) | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5656286A (en) | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5082866A (en) * | 1988-06-01 | 1992-01-21 | Odontex, Inc. | Biodegradable absorption enhancers |
| US5164406A (en) | 1988-06-02 | 1992-11-17 | Bristol-Myers Squibb Co. | Method for enhancing transdermal penetration and compositions useful therein |
| US5788983A (en) | 1989-04-03 | 1998-08-04 | Rutgers, The State University Of New Jersey | Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes |
| CA2020964A1 (en) | 1989-07-12 | 1991-01-13 | Emmett M. Partain, Iii | Pharmaceutical active derivative delivery systems |
| US5091186A (en) | 1989-08-15 | 1992-02-25 | Cygnus Therapeutic Systems | Biphasic transdermal drug delivery device |
| JPH0794378B2 (ja) | 1989-08-18 | 1995-10-11 | 久光製薬株式会社 | エアゾール剤 |
| JPH0383924A (ja) | 1989-08-28 | 1991-04-09 | Kanebo Ltd | 経皮投与用組成物 |
| IL95952A0 (en) | 1989-10-19 | 1991-07-18 | Sterling Drug Inc | Aerosol composition for topical medicament |
| JP3046346B2 (ja) | 1990-03-12 | 2000-05-29 | 昭和電工株式会社 | 外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤 |
| US5118494A (en) | 1990-03-23 | 1992-06-02 | Minnesota Mining And Manufacturing Company | Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
| JP2974081B2 (ja) | 1990-07-26 | 1999-11-08 | 小池化学株式会社 | 人体用エアゾール組成物 |
| DE69105212T2 (de) | 1990-10-18 | 1995-03-23 | Minnesota Mining And Mfg. Co., Saint Paul, Minn. | Aerosolzubereitung, die beclometason 17,21-dipropionat enthält. |
| US5122383A (en) | 1991-05-17 | 1992-06-16 | Theratech, Inc. | Sorbitan esters as skin permeation enhancers |
| DE69222182T2 (de) | 1991-12-18 | 1998-02-26 | Warner Lambert Co | Verfahren für die herstellung einer festen dispersion |
| EP0560014A1 (en) | 1992-03-12 | 1993-09-15 | Atrix Laboratories, Inc. | Biodegradable film dressing and method for its formation |
| HU221598B (hu) | 1992-06-11 | 2002-11-28 | Theratech Inc. | Glicerin alkalmazása bőrön keresztüli hatóanyag-bevitel szabályozására |
| EP0581587A3 (en) | 1992-07-31 | 1995-05-17 | Tanabe Seiyaku Co | Basis for percutaneous administration. |
| DE4230588C1 (de) | 1992-09-12 | 1993-10-07 | Lohmann Therapie Syst Lts | Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung |
| US5613958A (en) | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
| DE4334553C2 (de) * | 1993-10-11 | 1998-05-20 | Synopharm Gmbh Pharmazeutische | Flüssiges pharmazeutisches System zur perkutanen Applikation |
| DE4446600A1 (de) | 1994-12-24 | 1996-06-27 | Lohmann Therapie Syst Lts | Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen |
| US6416760B2 (en) | 1995-01-26 | 2002-07-09 | Societe L'oreal | Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin |
| GB9504265D0 (en) | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
| FR2732223B1 (fr) | 1995-03-30 | 1997-06-13 | Sanofi Sa | Composition pharmaceutique pour administration transdermique |
| US5780050A (en) | 1995-07-20 | 1998-07-14 | Theratech, Inc. | Drug delivery compositions for improved stability of steroids |
| US6916487B2 (en) * | 1996-02-19 | 2005-07-12 | Acrux Dds Pty Ltd | Transdermal delivery of antiemetics |
| US6929801B2 (en) * | 1996-02-19 | 2005-08-16 | Acrux Dds Pty Ltd | Transdermal delivery of antiparkinson agents |
| AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
| US6923983B2 (en) | 1996-02-19 | 2005-08-02 | Acrux Dds Pty Ltd | Transdermal delivery of hormones |
| US7094422B2 (en) | 1996-02-19 | 2006-08-22 | Acrux Dds Pty Ltd. | Topical delivery of antifungal agents |
| US6998138B2 (en) | 1996-02-19 | 2006-02-14 | Acrux Dds Pty. Ltd. | Topical delivery of anti-alopecia agents |
| US6916486B2 (en) * | 1996-02-19 | 2005-07-12 | Acrux Dds Pty Ltd | Transdermal delivery of analgesics |
| US6004969A (en) * | 1996-04-15 | 1999-12-21 | National Science Council | Transdermal delivery of buprenorphine preparations |
| DE19616539A1 (de) * | 1996-04-25 | 1997-11-06 | Luitpold Pharma Gmbh | Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel |
| US6638948B1 (en) | 1996-09-09 | 2003-10-28 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
| AUPO379596A0 (en) * | 1996-11-22 | 1996-12-19 | Soltec Research Pty Ltd | Percutaneous delivery system |
| DE19701949A1 (de) | 1997-01-13 | 1998-07-16 | Jenapharm Gmbh | Transdermales therapeutisches System |
| IT1294748B1 (it) | 1997-09-17 | 1999-04-12 | Permatec Tech Ag | Formulazione per un dispositivo transdermico |
| US5968919A (en) | 1997-10-16 | 1999-10-19 | Macrochem Corporation | Hormone replacement therapy drug formulations for topical application to the skin |
| DE69840426D1 (de) | 1997-11-10 | 2009-02-12 | Strakan Int Ltd | Penetrationsfördernde und irritationsvermindernde Systeme mit Testosteron |
| EP0919550A1 (en) | 1997-11-26 | 1999-06-02 | Ucb, S.A. | Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride |
| AU749697B2 (en) | 1998-08-04 | 2002-07-04 | Jagotec Ag | Medicinal aerosol formulations |
| US5962505A (en) | 1998-08-31 | 1999-10-05 | Bobrove; Arthur M. | Method for treating hot flashes in humans |
| DE19843027A1 (de) * | 1998-09-19 | 2000-03-23 | Labtec Gmbh | Neohesperidin DC als Kristallisationsinhibitor |
| US6663874B2 (en) * | 1998-11-02 | 2003-12-16 | Victor Stevens | Composition to alleviate pain and topical method of applying same |
| ES2209812T3 (es) * | 1999-02-05 | 2004-07-01 | Cipla Ltd. | Pulverizaciones topicas que contienen una composicion filmogena. |
| DE19906152B4 (de) | 1999-02-10 | 2005-02-10 | Jenapharm Gmbh & Co. Kg | Wirkstoffhaltige Laminate für Transdermalsysteme |
| US6399093B1 (en) * | 1999-05-19 | 2002-06-04 | Advanced Medical Instruments | Method and composition to treat musculoskeletal disorders |
| JP2001270826A (ja) | 1999-09-28 | 2001-10-02 | Shoei:Kk | 皮膚疾患治療・予防用外用剤 |
| WO2001032115A1 (en) | 1999-11-04 | 2001-05-10 | Xel Herbaceuticals | Transdermal administration of huperzine |
| US20010041716A1 (en) * | 1999-12-02 | 2001-11-15 | Laing Timothy J. | Compositions and methods for locally treating inflammatory diseases |
| US6432415B1 (en) | 1999-12-17 | 2002-08-13 | Axrix Laboratories, Inc. | Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| JP2004159666A (ja) * | 1999-12-21 | 2004-06-10 | Ya Man Ltd | レーザ脱毛器 |
| IN191512B (enExample) * | 2000-01-21 | 2003-12-06 | Panacea Biotech | |
| US6562790B2 (en) | 2000-02-05 | 2003-05-13 | Chein Edmund Y M | Hormone therapy methods and hormone products for abating coronary artery blockage |
| US6387383B1 (en) | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
| IN191090B (enExample) * | 2000-08-29 | 2003-09-20 | Ranbanx Lab Ltd | |
| JP2004524267A (ja) | 2000-08-30 | 2004-08-12 | ユニメッド・ファーマシューティカルズ・インコーポレーテッド | 男性の勃起障害の治療方法、及び性衝動の増強方法 |
| NZ536633A (en) | 2000-08-30 | 2006-03-31 | Unimed Pharmaceuticals Inc | Percutaneous delivery of testosterone via a hydroalcoholic gel as a method of increasing testosterone and related steroid concentrations in women |
| US20030139384A1 (en) | 2000-08-30 | 2003-07-24 | Dudley Robert E. | Method for treating erectile dysfunction and increasing libido in men |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US6682757B1 (en) | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
| GB0029634D0 (en) * | 2000-12-05 | 2001-01-17 | Norway Medical Group Int As | Use |
| US6743448B2 (en) | 2000-12-11 | 2004-06-01 | Abraham H. Kryger | Topical testosterone formulations and associated methods |
| JP2005523252A (ja) | 2002-01-26 | 2005-08-04 | マイクロ サイエンス テック コーポレーション リミテッド | 牧丹皮抽出物を有効成分として含む組成物 |
| US20030199584A1 (en) | 2002-04-11 | 2003-10-23 | Ahluwalia Gurpreet S. | Reduction of hair growth |
| US20050186141A1 (en) | 2002-06-25 | 2005-08-25 | Acrux Dds Pty Ltd. | Transdermal aerosol compositions |
| US20050181032A1 (en) | 2002-06-25 | 2005-08-18 | Acrux Dds Pty Ltd. | Metastable pharmaceutical compositions |
| EP1534235B1 (en) | 2002-06-25 | 2016-07-27 | Acrux DDS Pty Ltd | Transdermal delivery rate control using amorphous pharmaceutical compositions |
| AUPS317102A0 (en) * | 2002-06-25 | 2002-07-18 | Drug Delivery Solutions Pty Ltd | Transdermal aerosol compositions |
| US8206696B2 (en) | 2002-12-30 | 2012-06-26 | Aplicare, Inc. | Antimicrobial skin preparation |
| GB0302662D0 (en) | 2003-02-05 | 2003-03-12 | Strakan Ltd | Transdermal granisetron |
| FR2851470B1 (fr) | 2003-02-20 | 2007-11-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse |
| CA2433101A1 (en) | 2003-06-23 | 2004-12-23 | Igor Gonda | Method of treatment of a female suffering from androgen insufficiency |
| US20050025833A1 (en) | 2003-07-16 | 2005-02-03 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
| US20050042268A1 (en) | 2003-07-16 | 2005-02-24 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
| US20050020552A1 (en) | 2003-07-16 | 2005-01-27 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
| DK1670433T3 (da) | 2003-10-10 | 2012-03-12 | Ferring Bv | Transdermal farmaceutisk formulering til mindskelse af hudrester |
| MXPA06005743A (es) | 2003-11-19 | 2007-04-17 | Acrux Dds Pty Ltd | Metodo y composicion para el tratamiento o profilaxis de trastornos de amiloidosis. |
| US20050123576A1 (en) | 2003-12-03 | 2005-06-09 | Ilana Lavon | Mupirocin compositions for topical use, an improved process of making same and methods of using same |
| EP2656859B1 (en) | 2004-03-03 | 2015-10-21 | ReVance Therapeutics, Inc. | Topical application and transdermal delivery of botulinum toxins |
| EP1634583A1 (en) | 2004-09-09 | 2006-03-15 | Laboratoires Besins International | Testosterone gels comprising propylene glycol as penetration enhancer |
| ES2607454T3 (es) | 2005-06-03 | 2017-03-31 | Acrux Dds Pty Ltd | Método y composición para el suministro transdérmico de testosterona |
-
2003
- 2003-06-24 EP EP03729716.5A patent/EP1534235B1/en not_active Revoked
- 2003-06-24 KR KR1020107009520A patent/KR20100055542A/ko not_active Ceased
- 2003-06-24 KR KR1020047021362A patent/KR20050045946A/ko not_active Ceased
- 2003-06-24 JP JP2004514440A patent/JP5160018B2/ja not_active Expired - Fee Related
- 2003-06-24 WO PCT/AU2003/000787 patent/WO2004000263A1/en not_active Ceased
- 2003-06-24 CA CA2489865A patent/CA2489865C/en not_active Expired - Fee Related
- 2003-06-24 BR BRPI0312007-4A patent/BRPI0312007B1/pt not_active IP Right Cessation
- 2003-06-24 EA EA200500084A patent/EA009024B1/ru not_active IP Right Cessation
- 2003-06-24 NZ NZ537360A patent/NZ537360A/en not_active IP Right Cessation
- 2003-06-24 EP EP10010704A patent/EP2266533A3/en not_active Withdrawn
- 2003-06-24 ES ES03729716.5T patent/ES2589077T3/es not_active Expired - Lifetime
- 2003-06-24 AU AU2003240301A patent/AU2003240301B2/en not_active Ceased
-
2004
- 2004-12-07 US US11/004,926 patent/US8357393B2/en not_active Expired - Fee Related
-
2009
- 2009-12-18 US US12/642,301 patent/US20100166674A1/en not_active Abandoned
-
2012
- 2012-04-12 JP JP2012090664A patent/JP5568108B2/ja not_active Expired - Fee Related
- 2012-12-11 US US13/710,761 patent/US8784878B2/en not_active Expired - Fee Related
-
2014
- 2014-06-16 US US14/305,529 patent/US20150094290A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012162557A5 (enExample) | ||
| CN114206325B (zh) | 用于生成一氧化氮的方法和组合物及其用途 | |
| US8784878B2 (en) | Transdermal delivery rate control using amorphous pharmaceutical compositions | |
| CN114126629A (zh) | 用于生成一氧化氮的方法和组合物及其用于经由呼吸道输送一氧化氮的用途 | |
| JP2011502173A5 (enExample) | ||
| JP2009542657A (ja) | ゲルの形態でのロピニロール含有薬学的組成物、その使用 | |
| NZ703574A (en) | A topical composition comprising a film-forming polymer for delivering an active ingredient to skin | |
| TWI713481B (zh) | 膏劑 | |
| TW201431570A (zh) | 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片 | |
| US9168235B2 (en) | Aqueous patches containing diclofenac sodium | |
| JP2014177428A (ja) | ロジン系樹脂を含有するロチゴチン経皮吸収型貼付製剤 | |
| JP5615899B2 (ja) | 経皮吸収製剤 | |
| JP7049258B2 (ja) | 水性貼付剤 | |
| WO2015070156A1 (en) | Rapidly disintegrating formulations and methods of use | |
| EP3342423B1 (en) | Transdermally absorptive composition | |
| RU2013141836A (ru) | Способы и композиции для лечения болезни рейно | |
| WO2017164084A1 (ja) | 誤用防止特性を有する貼付製剤 | |
| JP2007509122A (ja) | Ｖｐ／ｖａ共重合体及び非水性ビヒクルを含有する、経皮的医薬スプレー製剤 | |
| AU2017317523B2 (en) | Pharmaceutical solution of Asenapine for sublingual or buccal use | |
| TWI526227B (zh) | 含有洛索普洛芬鈉之外用貼附劑 | |
| TW201713316A (zh) | 經皮吸收型貼付劑 | |
| CN107148284A (zh) | 水性外用制剂 | |
| JP6675589B2 (ja) | 経皮吸収型製剤 | |
| TW201129660A (en) | Dermal absorption agent comprising felbinac | |
| WO2017178966A1 (en) | Topical spray formulation of glycopyrrolate |